Ir o contido principal
CiMUS Seminar

"How biotech innovations make it to market: A case study of COVID-19 mRNA vaccines"

Paul Burke, PhD

Principal. Burke Bioventures LLC. Cambridge (Massachusetts, USA)

20 Outubro 2022 12:30–13:30

Theatre Room, CiMUS

Bio:

Dr. Paul Burke is Principal of Burke Bioventures, a Cambridge, Massachusetts-based biotechnology consultancy focused on translating research breakthroughs-particularly those based on nano-technology, targeting, and RNA-into products. Dr. Burke was formerly the founding head of Pfizer's global Center of Excellence for targeted drug delivery and imaging, and Chief Technology Officer of the Oligonucleotide Therapeutics Unit. Previously he was Executive Director, RNA Therapeutics at Merck & Co. where he led delivery R&D, charged with developing enabling technologies for maximizing value from the company?s $1.1B acquisition of Sirna Therapeutics 
Dr. Burke joined Merck following a decade-long tenure at Amgen, where he held positions of increasing responsibility including his most recent as Executive Director, Pharmaceutics. In this role he launched new technology initiatives for extending product lines (including Aranesp® and Neulasta®) and for integrating drug delivery in the discovery pipeline, with a focus on enablement of new therapeutic classes. Prior to Amgen Dr. Burke held staff scientist positions at Alkermes and Mitsubishi Kasei (now Mitsubishi Tanabe Pharma). 
Dr. Burke received his B.S. in Chemistry with Distinction and Departmental Honors from Harvey Mudd College and his Ph.D. in Biological Chemistry from MIT. He is an Affiliate Professor of Bioengineering at the University of Washington and, for the winter 2017 term, was the Distinguished Visiting Professor at City of Hope's Beckman Research Institute.

Hosted by María José Alonso

Attendance certificates will be provided upon request to cimus.xestion [at] usc.es. Please bear in mind to register by writing clearly the name and surname on the printed sheet. We will not be responsible for amending the records of anyone who fails to do so.